Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 28Breast Neoplasms 17Colorectal Neoplasms 14Prostatic Neoplasms 13Hematologic Neoplasms 7Ovarian Neoplasms 6Lung Neoplasms 6Leukemia 5Uterine Cervical Neoplasms 4Rectal Neoplasms 4Pancreatic Neoplasms 4Lymphoma 4Endometrial Neoplasms 4Stomach Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pain 3Leukemia, Myeloid, Acute 3Head and Neck Neoplasms 3Genetic Predisposition to Disease 3Disease 3Colorectal Neoplasms, Hereditary Nonpolyposis 3Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Neoplasms, Plasma Cell 2Multiple Myeloma 2Mouth Neoplasms 2Motor Activity 2Melanoma 2Low Anterior Resection Syndrome 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2

Interventions

Methadone 2oxycodone naloxone combination 1Tapentadol 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Pharmacogenomic Testing 1Oxycodone 1Morphine 1Interviews as Topic 1Hydromorphone 1Focus Groups 1Fentanyl 1Diagnostic Tests, Routine 1Buprenorphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cancer Pain × Interviews as Topic × Clear all
NCT01230515 2012-09-10

Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol

Vanderbilt-Ingram Cancer Center

Completed
65 enrolled

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡